跳至主要内容
临床试验/NCT07394673
NCT07394673尚未招募不适用

Postoperative Analgesic Efficacy of Ultrasound-Guided Serratus Posterior Superior Intercostal Plane Block in Arthroscopic Shoulder Surgery

Bursa City Hospital1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2026年2月20日最近更新:
干预措施

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
80
试验地点
1
主要终点
Postoperative 48-Hour PCA Opioid Consumption

研究概览

简要总结

This study aimed to evaluate the effectiveness of serratus posterior superior intercostal plane (SPSIP) block in managing postoperative pain in patients undergoing arthroscopic shoulder surgery.

详细描述

Most patients undergoing arthroscopic shoulder surgery report pain in the postoperative period. Pain management remains a significant concern in patient management, as it affects surgical costs, postoperative mobility, length of hospital stay, patient satisfaction, and surgical outcomes. Multimodal analgesia is recommended for the management of postoperative pain. Regional analgesia is an important component of multimodal analgesia.

The serratus posterior superior intercostal plane (SPSIP) block is a novel regional analgesia technique described in 2023. SPSIP has been reported to provide near-complete sensory blockade in the posterior neck, shoulder, and hemithorax regions.

The main objective of this study is to investigate the effectiveness of SPSIP block in patients undergoing arthroscopic shoulder surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Care Provider, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Classified as American Society of Anesthesiologists (ASA) physical status I-II-III
  • Scheduled for elective shoulder arthroscopy surgery
  • Surgery performed under general anesthesia
  • Provision of written informed consent

排除标准

  • Use of anticoagulant or antiplatelet medications
  • Presence of bleeding diathesis or coagulation disorders
  • Known allergy or hypersensitivity to local anesthetics or opioid medications
  • Infection or history of previous surgery at the planned block site
  • Alcohol or drug dependence
  • Cognitive impairment preventing reliable pain assessment using the NRS
  • Pregnancy or lactation
  • Diabetes mellitus
  • Renal or hepatic impairment

研究组 & 干预措施

Group SPSIP

Active Comparator

Group SPSIP Participants in this arm will receive an ultrasound-guided serratus posterior plane block .

干预措施: Group SPSIP: Serratus Posterior Superior İntercostal Plane Block (SPSIP) (Procedure)

Group Control

No Intervention

No block procedures will be performed on patients in this arm

结局指标

主要结局

Postoperative 48-Hour PCA Opioid Consumption

时间窗: Postoperative 0-8, 8-16, 16-24, 24-48 intervals

Total amount of opioid delivered by the patient-controlled analgesia (PCA) device during the first 48 hours after surgery, recorded in milligrams(mg)

次要结局

  • QoR-15 Recovery Score(Postoperative 24th and 48th hours)
  • Dynamic and static NRS scores(0, 2, 4, 8, 16, 24, and 48 hours postoperatively)
  • Total rescue analgesic dose(Postoperative 24th and 48th hours)
  • Time of first request for rescue analgesia,(Postoperative 48-Hours)
  • Length of Hospital Stay(the day of surgery, the day of discharge from the hospital)
  • Block and Opioid-Related Adverse Effects and Complications(Postoperative 48-Hours)
  • Perioperative Remifentanil infusion dose(Start time: Start of anesthesia administration End time: Termination of anesthesia administration)

研究者

发起方
Bursa City Hospital
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Merih Yıldız Eglen

Principal Investigator, MD

Bursa City Hospital

研究点 (1)

Loading locations...

相似试验